Vident Investment Advisory’s MorphoSys AG American Depositary Shares MOR Stock Holding History

Vident Investment Advisory’s Portfolio MOR Stock Details MOR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-58,814	Closed	-$1.28M	–	1120
2021 Q1	$1.28M	Hold	58,814	–	–	0.04%	546
2020 Q4	$1.67M	Buy	58,814 +15,384	+35%	+$421K	0.07%	355
2020 Q3	$1.36M	Sell	43,430 -2,896	-6%	-$93.8K	0.07%	405
2020 Q2	$1.47M	Buy	46,326 +5,737	+14%	+$167K	0.08%	330
2020 Q1	$997K	Sell	40,589 -2,796	-6%	-$82.3K	0.07%	398
2019 Q4	$1.55M	Sell	43,385 -13,305	-23%	-$397K	0.1%	328
2019 Q3	$1.56M	Sell	56,690 -1,620	-3%	-$46.4K	0.14%	107
2019 Q2	$1.41M	Buy	58,310 +3,041	+6%	+$75.4K	0.11%	128
2019 Q1	$1.26M	Sell	55,269 -1,454	-3%	-$38.2K	0.07%	376
2018 Q4	$1.44M	Sell	56,723 -25,178	-31%	-$661K	0.08%	332
2018 Q3	$2.19M	Sell	81,901 -5,872	-7%	-$176K	0.09%	307
2018 Q2	$2.66M	Buy	+87,773	New	+$2.41M	0.11%	266

Other funds holding MOR

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

ALPS Advisors Denver, Colorado $21.3B AUM 21.71% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

TCM

Tekla Capital Management Boston, Massachusetts $2.56B AUM 18.15% 1-Year Est. Return

HJIM

Henry James International Management New York $334M AUM 49.44% 1-Year Est. Return

AlphaCentric Advisors San Juan, Puerto Rico $118M AUM

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Vident Investment Advisory's MOR Position: Q2 2021 in Review

Vident Investment Advisory sold out of MorphoSys AG American Depositary Shares (MOR) in Q2 2021, closing a stake of 58,814 shares — an estimated $1.28M sold.

Vident Investment Advisory first reported a position in MOR in Q2 2018 and held it in 12 quarters. The position peaked at $2.66M in Q2 2018. 26 funds tracked by Wall St. Rank hold MOR as of Q2 2021.

Vident Investment Advisory reported no remaining MorphoSys AG American Depositary Shares position as of Q2 2021 after selling out during the quarter.
Vident Investment Advisory sold 58,814 MorphoSys AG American Depositary Shares shares in Q2 2021, an estimated $1.28M.
Vident Investment Advisory first reported a position in MorphoSys AG American Depositary Shares in Q2 2018 and held it in 12 quarters.
Vident Investment Advisory's MorphoSys AG American Depositary Shares position peaked at $2.66M in Q2 2018.
26 funds tracked by Wall St. Rank held MorphoSys AG American Depositary Shares as of Q2 2021.

Based on Vident Investment Advisory's 13F filing for Q2 2021, filed 13 Aug 2021.